Michael P Bailey
CIK 1255856 · President & CEO · last filed 2026-05-27
Michael P Bailey is a President & CEO who has filed 33 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for VSTM, was dated May 27, 2026. Across all open-market trades the lifetime net is −$843.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $931.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IMCL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
180 VARICK STREET, 6TH FLOOR
NEW YORK, NY 10014
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VSTM | Director | 108,000 | $8.62 | $931.0K | $0 | 1 | 2026-05-27 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | President & CEO | 0 | $15.00 | $0 | $158.5K | 23 | 2023-01-19 |
| MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted | Sr. VP, Chief Comm. Officer | 29,627 | — | — | -$12.8K | 4 | 2010-08-06 |
| IMCLONE SYSTEMS INC (IMCL) Delisted | SVP, Commercial Ops | 9,280 | — | — | -$989.0K | 5 | 2008-08-01 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-27 | VSTM | Grant (A) | +108,000 | $0 | EDGAR |
| 2023-01-19 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Disp (D) | −333,167 | -$5.00M | EDGAR |
| 2022-12-22 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Exer (M) | +276,746 | $1.25M | EDGAR |
| 2022-02-17 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-03 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +15,000 | $97.2K | EDGAR |
| 2021-04-16 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-07 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-25 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +150,000 | $89.6K | EDGAR |
| 2019-02-08 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-02 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.